The patient perspective

Steve Schwarze, PALTOWN’s Director of Clinical Trials Programming and a stage IV CRC patient, gets into the details for you:

  • the most important biomarkers CRC patients should know
  • specific types of biomarker testing
  • how precision medicine tools can provide new information to discuss with your care team
  • some of the practical considerations for using these tools and working with your care team.
Previous Topic
Back to Learning Center
Next Topic